ReShape Lifesciences slumps after $6 mln public offering

Vyome Holdings

18/02/2025 13:19

** Shares of metabolic health solutions firm ReShape
Lifesciences  RSLS.O  fall 57.5% to $1 premarket
    ** On Saturday, RSLS said it is raising $6 mln through a
public offering of shares and warrants
    ** Co selling ~2.6 mln units, each consisting of one share
and one warrant, at $2.33 per unit
    ** Warrants can be exercised at a price of $5.83 per share,
after stockholder approval
    ** Maxim Group LLC is acting as the sole agent for the
offering
    ** RSLS fell ~71% in 2024

 (Reporting by Kamal Choudhury in Bengaluru)
 ((Kamal.Choudhury@thomsonreuters.com;))